Messenger Ribonucleic Acid Quality Monitoring Market Growth To $2.49 Billion By 2030: What’s Driving The Expansion?
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Messenger Ribonucleic Acid Quality Monitoring Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The messenger ribonucleic acid quality monitoring market has seen substantial growth recently. Its valuation is predicted to rise from $1.47 billion in 2025 to $1.64 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.3%. The drivers for this historic expansion include the broadening of mRNA research applications, the initial adoption of analytical validation tools, the rise in academic and clinical research programs, the increasing utilization of mRNA in vaccine development, and the accessibility of specialized quality control reagents.
The messenger ribonucleic acid quality monitoring market is poised for significant expansion in the coming years. This market is projected to reach $2.49 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.0%. This anticipated growth stems from several factors, including the expansion of therapeutic mRNA pipelines, heightened regulatory oversight of mRNA products, increased investment in biopharmaceutical manufacturing, the growing use of real-time quality analytics, and the broader provision of contract research and manufacturing services. Key developments during this period will involve the increasing embrace of standardized mRNA quality control protocols, a rise in the utilization of advanced analytical instrumentation, the growing incorporation of automated quality monitoring systems, the broadening of regulatory compliance testing, and a stronger emphasis on mRNA stability and integrity.
Get A Free Sample Report With In-Depth Market Insights:
Messenger Ribonucleic Acid Quality Monitoring Market Expansion Drivers: What’s Shaping Future Growth?
The rising demand for personalized medicines is anticipated to propel the expansion of the messenger ribonucleic acid quality monitoring market moving forward. Personalized medicines are defined as medical treatments specifically adapted to an individual’s genetic makeup, lifestyle, and environment, aiming to provide the most effective therapy for that particular patient. This heightened demand for personalized medicines arises from the increasing prevalence of chronic and rare diseases, which necessitate targeted, patient-specific therapies to achieve better treatment outcomes. Messenger ribonucleic acid quality monitoring plays a crucial role by ensuring the accuracy, stability, and efficacy of mRNA-based therapies, thereby directly supporting the creation of safe and effective personalized medicines. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA approved 16 new personalized therapies for patients with rare diseases, demonstrating a substantial increase from the 6 approvals registered in 2022. Thus, the growing demand for personalized medicines is a key driver for the growth of the messenger ribonucleic acid quality monitoring market.
Messenger Ribonucleic Acid Quality Monitoring Market Segment Analysis: What Are The Core Market Categories?
The messenger ribonucleic acid quality monitoring market covered in this report is segmented –
1) By Type: Analytical Instruments, Reagents And Consumables, Software And Services
2) By Technology: Liquid Chromatography-Mass Spectrometry (LC-MS), Electrophoresis, Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR) Techniques, Other Technologies
3) By Application: Vaccine Development, Therapeutic Messenger Ribonucleic Acid Products, Gene Editing
4) By End User: Biopharmaceutical And Biotechnology Companies, Contract Development And Manufacturing Organizations (CDMOs), Contract Research Organizations (CROs) And Analytical Labs, Academic And Research Institutes Or Centers
Subsegments:
1) By Analytical Instruments: Benchtop Analyzers, Microfluidic Systems, Spectrophotometers, Capillary Electrophoresis Systems
2) By Reagents And Consumables: Ribonucleic Acid Extraction Kits, Complementary Deoxyribonucleic Acid Synthesis Kits, Fluorescent Probes, Quality Control Standards
3) By Software And Services: Data Analysis Software, Laboratory Information Management Systems, Consulting Services, Validation And Training Services
Messenger Ribonucleic Acid Quality Monitoring Market Strategic Trends: What Defines The Next Growth Phase?
Major companies operating in messenger ribonucleic acid quality monitoring are focusing on developing innovative solutions, such as benchtop instruments, for rapid and accurate assessment of messenger ribonucleic acid quality attributes. A benchtop instrument is a compact laboratory device designed to perform specialized analyses or experiments on a laboratory bench, offering convenience, speed, and accessibility without the need for large-scale equipment. For instance, in June 2024, InDevR Inc., a US-based biotechnology and analytical instrumentation company, launched 5’CapQ, a rapid benchtop assay for assessing critical quality attributes (CQAs) of mRNA-based vaccines. The assay measures both the integrity and 5’ capping efficiency of mRNA molecules in under two hours, combining these key quality metrics into a single streamlined test. It works by selectively capturing mRNA molecules with a 5’ cap and fluorescently labeling the poly(A) tail, ensuring that only fully intact, capped mRNA essential for stability and protein translation is quantified. By providing fast, quantitative, and easy-to-use analysis, 5’CapQ helps eliminate testing bottlenecks in mRNA vaccine development without requiring specialized expertise or lengthy processing times.
Messenger Ribonucleic Acid Quality Monitoring Market Top Companies Driving Competitive Growth
Major companies operating in the messenger ribonucleic acid quality monitoring market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Lonza Group AG, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Intertek Group plc, Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., WuXi Biologics (Cayman) Inc., QIAGEN N.V., Bio-Techne Corporation, Fujifilm Diosynth Biotechnologies, GenScript Biotech Corporation, Promega Corporation, Takara Bio Inc., Oxford Nanopore Technologies Ltd., Creative Biolabs Inc., Creative Diagnostics, Jena Bioscience GmbH.
View The Full Messenger Ribonucleic Acid Quality Monitoring Market Report:
Messenger Ribonucleic Acid Quality Monitoring Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the messenger ribonucleic acid quality monitoring market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the messenger ribonucleic acid quality monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
